Cherington Charles Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$1.25M
Insider Sells Quantity
2
Insider Sells Sum
$6.3M

Insider Activity of Cherington Charles

According to the SEC Form 4 filings, Cherington Charles, being in a position of

  1. 10 percent owner at Ernexa Therapeutics Inc.,
    оver the last 12 months, has bought 4000000 shares for $2M, and sold 0 shares,
    over all time since 2021-06-16, has bought 42523428 shares for $9.85M, and sold 400000 shares for $6.3M.

Biography of Cherington Charles

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $2,000,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-02-10PurchaseErnexa Therapeutics Inc.
ERNA
10 percent owner
4M
83.4958%
$0.50$2M-34.4%
2025-06-09PurchaseEterna Therapeutics Inc.
ERNA
10 percent owner
21.24M
18.8502%
$0.10$2.22M-56.34%
2025-04-02PurchaseEterna Therapeutics Inc.
ERNA
10 percent owner
3.77M
3.9501%
$0.10$394,174-52.61%
2024-10-29PurchaseEterna Therapeutics Inc.
ERNA
10 percent owner
13.25M
–
$2.41M$31,999.46B-81.7%
2024-09-24PurchaseEterna Therapeutics Inc.
ERNA
10 percent owner
13.25M
20.0594%
$0.33$4.38M-78.55%
2022-12-02PurchaseEterna Therapeutics Inc.
ERNA
director
261,756
3.9322%
$3.28$858,560-16.36%
2021-06-17SaleEterna Therapeutics Inc.
ERNA
200,000
14.426%
$15.75$3.15M-67.47%
2021-06-16SaleEterna Therapeutics Inc.
ERNA
200,000
14.412%
$15.73$3.15M-67.72%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.